Cue biopharma announces the appointment of dr. rafi ahmed to its scientific advisory board

Boston, feb. 16, 2023 (globe newswire) -- cue biopharma, inc. (nasdaq: cue), a clinical-stage biopharmaceutical company developing a novel class of injectable biologics to selectively engage and modulate disease-specific t cells directly within the patient's body, announced today that world-renowned immunologist and distinguished thought leader dr. rafi ahmed, ph.d., has joined its scientific advisory board (sab).
CUE Ratings Summary
CUE Quant Ranking